Mayo researcher to lead HHS Alzheimer's council

Justine Varieur Cadet | | Health Imaging | Molecular Imaging
Ronald Petersen, MD, director of the Mayo Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging, was selected to chair the Advisory Council on Alzheimer’s Research, Care and Services. The formation of the group was announced Aug. 23 by the U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius.

The 12 non-federal council members include Alzheimer's disease patient advocates, caregivers and healthcare providers. They will advise the secretary on federal programs that impact people with Alzheimer’s disease and related dementia. Alzheimer’s disease affects 5.1 million people in the U.S. and is expected to impact more than 20 million people by 2050, according to a statement from Mayo, which is located in Rochester, Minn.

The advisory council will meet quarterly to help develop a nationwide plan involving HHS, the Department of Veterans Affairs, the Department of Defense and the National Science Foundation. The council is required by the National Alzheimer’s Project Act. Its members will serve four-year terms.

Justine Varieur Cadet

Related Content

Dementia cases are about to skyrocket—how will this affect imaging demand?
Experts update AUC for amyloid, tau PET imaging for first time in more than a decade
Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'
Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.